A Study of Bevacizumab (Avastin) in Participants With Newly Diagnosed Locally Advanced Rectal Cancer
Status:
Completed
Trial end date:
2016-03-23
Target enrollment:
Participant gender:
Summary
This study will assess the efficacy and safety of two different neoadjuvant treatment
approaches including bevacizumab in newly diagnosed participants with high risk locally
advanced rectal cancer. Participants will be randomized into one of two treatment arms (Arm A
or Arm B).